- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.06 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 01: (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-chloranyl-phenyl]carbonylamino]pentanedioic acid
01.1: 16 residues within 4Å:- Chain A: Y.52, V.55, K.56, V.99, Q.100, L.101, D.125, L.127, I.176, I.238, P.272, G.273, G.276, P.277, V.280
- Ligands: NAP.2
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:V.280
- Hydrogen bonds: A:K.56, A:V.99, A:Q.100, A:L.101, A:L.101, A:G.273, A:G.276
- Water bridges: A:G.276, A:G.276
- Salt bridges: A:D.125
- pi-Stacking: A:Y.52
01.3: 16 residues within 4Å:- Chain B: Y.52, V.55, K.56, L.98, V.99, Q.100, L.101, D.125, L.127, I.238, P.272, G.273, G.276, P.277, V.280
- Ligands: NAP.4
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:V.55, B:V.280
- Hydrogen bonds: B:K.56, B:V.99, B:Q.100, B:L.101, B:L.101, B:G.273
- Water bridges: B:G.274, B:G.276
- Salt bridges: B:D.125
- pi-Stacking: B:Y.52
01.5: 16 residues within 4Å:- Chain C: Y.52, V.55, K.56, L.98, V.99, Q.100, L.101, D.125, L.127, I.238, P.272, G.273, G.276, P.277, V.280
- Ligands: NAP.6
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:V.55, C:V.280
- Hydrogen bonds: C:K.56, C:V.99, C:Q.100, C:L.101, C:L.101, C:G.273, C:G.276
- Water bridges: C:G.274, C:G.276
- Salt bridges: C:D.125
- pi-Stacking: C:Y.52
01.7: 16 residues within 4Å:- Chain D: Y.52, V.55, K.56, V.99, Q.100, L.101, D.125, L.127, I.176, I.238, P.272, G.273, G.276, P.277, V.280
- Ligands: NAP.8
13 PLIP interactions:13 interactions with chain D- Hydrophobic interactions: D:V.55, D:V.280
- Hydrogen bonds: D:K.56, D:V.99, D:Q.100, D:L.101, D:L.101, D:G.273
- Water bridges: D:V.99, D:G.276, D:G.276
- Salt bridges: D:D.125
- pi-Stacking: D:Y.52
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, H.H. et al., Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization. J.Med.Chem. (2024)
- Release Date
- 2025-01-01
- Peptides
- C-1-tetrahydrofolate synthase, cytoplasmic: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.06 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 01: (2~{S})-2-[[4-[[2,4-bis(azanyl)-6-oxidanylidene-1~{H}-pyrimidin-5-yl]carbamoylamino]-3-chloranyl-phenyl]carbonylamino]pentanedioic acid
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, H.H. et al., Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization. J.Med.Chem. (2024)
- Release Date
- 2025-01-01
- Peptides
- C-1-tetrahydrofolate synthase, cytoplasmic: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D